141 related articles for article (PubMed ID: 2576431)
21. An inhibitory effect of isoprenaline on stimulation-induced noradrenaline release from rat atria.
Mian MA; Majewski H; Rand MJ
Eur J Pharmacol; 1992 Mar; 213(1):47-51. PubMed ID: 1354162
[TBL] [Abstract][Full Text] [Related]
22. Comparison of the beta-adrenoceptor affinity and selectivity of cetamolol, atenolol, betaxolol, and ICI-118,551.
Rimele TJ; Henry DE; Giesa FR; Buckley SK; Geiger G; Heaslip RJ; Lee DK; Grimes D
J Cardiovasc Pharmacol; 1988 Aug; 12(2):208-17. PubMed ID: 2459552
[TBL] [Abstract][Full Text] [Related]
23. Mediation of the positive chronotropic effect of CGP 12177 and cyanopindolol in the pithed rat by atypical beta-adrenoceptors, different from beta 3-adrenoceptors.
Malinowska B; Schlicker E
Br J Pharmacol; 1996 Mar; 117(5):943-9. PubMed ID: 8851515
[TBL] [Abstract][Full Text] [Related]
24. Adrenaline in cardiovascular diseases--effect of beta-adrenoceptor antagonists.
Dehner R; Ikeda K; Yamori Y; Grobecker H
Z Kardiol; 1990; 79 Suppl 3():79-88. PubMed ID: 1983053
[TBL] [Abstract][Full Text] [Related]
25. Effects of ICI 141,292 on exercise tachycardia and isoprenaline-induced beta-adrenoceptor responses in man.
Pringle TH; O'Connor PC; McNeill AJ; Finch MB; Riddell JG; Shanks RG
Br J Clin Pharmacol; 1986 Mar; 21(3):249-58. PubMed ID: 2870732
[TBL] [Abstract][Full Text] [Related]
26. Presynaptic beta-adrenoceptors in rat atria: evidence for the presence of stereoselective beta 1-adrenoceptors.
Heimburger M; Montero MJ; Fougeres V; Beslot F; Davy M; Midol-Monnet M; Cohen Y
Br J Pharmacol; 1989 Sep; 98(1):211-7. PubMed ID: 2572291
[TBL] [Abstract][Full Text] [Related]
27. Beta adrenoceptor facilitation of norepinephrine release is not dependent on local angiotensin II formation in the rat isolated kidney.
Rump LC; Majewski H
J Pharmacol Exp Ther; 1987 Dec; 243(3):1107-12. PubMed ID: 2826755
[TBL] [Abstract][Full Text] [Related]
28. Co-released adrenaline markedly facilitates noradrenaline overflow through prejunctional beta 2-adrenoceptors during swimming exercise.
Coppes RP; Smit J; Benthem L; Van der Leest J; Zaagsma J
Eur J Pharmacol; 1995 Feb; 274(1-3):33-40. PubMed ID: 7768278
[TBL] [Abstract][Full Text] [Related]
29. The beta 1-adrenoceptor antagonist CGP 20712 A unmasks beta 2-adrenoceptors activated by (-)-adrenaline in rat sinoatrial node.
Kaumann AJ
Naunyn Schmiedebergs Arch Pharmacol; 1986 Apr; 332(4):406-9. PubMed ID: 2874503
[TBL] [Abstract][Full Text] [Related]
30. Does the beta 1-adrenoceptor blocking agent celiprolol have alpha 2-adrenoceptor blocking properties?
Pittner H
Arch Int Pharmacodyn Ther; 1987 Feb; 285(2):199-210. PubMed ID: 2883946
[TBL] [Abstract][Full Text] [Related]
31. Pharmacological, hemodynamic and autonomic nervous system mechanisms responsible for the blood pressure and heart rate lowering effects of pergolide in rats.
Cavero I; Lefevre-Borg F; Lhoste F; Sabatier C; Richer C; Giudicelli JF
J Pharmacol Exp Ther; 1984 Mar; 228(3):779-91. PubMed ID: 6707926
[TBL] [Abstract][Full Text] [Related]
32. The costo-uterine muscle of the rat contains a homogeneous population of beta-adrenoceptors.
Hartley ML; Pennefather JN
Br J Pharmacol; 1985 Feb; 84(2):463-8. PubMed ID: 2858239
[TBL] [Abstract][Full Text] [Related]
33. Effects of beta 1- and beta 2-adrenoceptor stimulation on hemodynamics in the anesthetized rat.
Abdelrahman A; Tabrizchi R; Pang CC
J Cardiovasc Pharmacol; 1990 May; 15(5):720-8. PubMed ID: 1692931
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of uptake 1 by (+)-oxaprotiline reveals a differential central regulation of noradrenaline and adrenaline release.
Szabo B; Auberle T; Starke K
Naunyn Schmiedebergs Arch Pharmacol; 1993 Sep; 348(3):249-57. PubMed ID: 8232602
[TBL] [Abstract][Full Text] [Related]
35. Role of β3-adrenoceptors in regulation of retinal vascular tone in rats.
Mori A; Nakahara T; Sakamoto K; Ishii K
Naunyn Schmiedebergs Arch Pharmacol; 2011 Dec; 384(6):603-8. PubMed ID: 21901314
[TBL] [Abstract][Full Text] [Related]
36. Effects of the alpha 2-adrenoceptor agonist UK14304 on pressor responses in pithed rats.
Xiao XH; Rand MJ
Clin Exp Pharmacol Physiol; 1990 Oct; 17(10):725-34. PubMed ID: 1980235
[TBL] [Abstract][Full Text] [Related]
37. Blood pressure lowering action and alpha-adrenolytic effect of adimolol in rats.
Palluk R; Hoefke W
Arch Int Pharmacodyn Ther; 1989; 301():215-27. PubMed ID: 2576194
[TBL] [Abstract][Full Text] [Related]
38. Opposite modulation of noradrenaline and ATP release in guinea-pig vas deferens through prejunctional beta-adrenoceptors: evidence for the beta 2 subtype.
Driessen B; Bültmann R; Gonçalves J; Starke K
Naunyn Schmiedebergs Arch Pharmacol; 1996 Apr; 353(5):564-71. PubMed ID: 8740151
[TBL] [Abstract][Full Text] [Related]
39. Effects of selective beta 2-adrenoceptor blockade on serum potassium and exercise performance in normal men.
Gullestad L; Birkeland K; Nordby G; Larsen S; Kjekshus J
Br J Clin Pharmacol; 1991 Aug; 32(2):201-7. PubMed ID: 1681847
[TBL] [Abstract][Full Text] [Related]
40. Peripheral alpha 2-adrenoceptor-mediated sympathoinhibitory effects of mivazerol.
Richer C; Gobert J; Noyer M; Wülfert E; Giudicelli JF
Fundam Clin Pharmacol; 1996; 10(6):529-37. PubMed ID: 8985723
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
